195
Views
0
CrossRef citations to date
0
Altmetric
Corrigendum

Corrigendum

Page 424 | Published online: 09 Jan 2014

After the publication of the Review by Bastiaan E de Galan, Can inhaled insulin be used for the treatment of diabetes mellitus?, published in the January 2008 issue of Expert Review of Pharmacoeconomics & Outcomes Research (Expert Rev. Pharmaco-economics Outcomes Res. 8[1], 33–42 [2008]), it has been brought to our attention that the following was written incorrectly:

Technosphere® insulin is a dry-powder pulmonary insulin packaged in microparticles to which an absorption enhancer is added.

The correct text is given below:

Technosphere® insulin (TI) is a dry-powder pulmonary insulin formation in which insulin is absorbed onto the surface of Technosphere® microparticles. TI does not contain any absorption enhancers. TI powder is appropriately sized for inhalation into the deep lung where the particles rapidly dissolve and insulin is absorbed by natural mechanisms.

The editors of Expert Review of Pharmacoeconomics & Outcomes Research and authors would like to sincerely apologize for any inconvenience or confusion this may have caused our readers.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.